In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Sanofi says it has won an arbitration dispute with Boehringer Ingelheim, in which the latter had tried to protect itself from liabilities that may arise from ongoing litigation over Zantac in the ...

The decision means that the defendants in the cases – which include GSK, its consumer health spin-off Haleon, Sanofi, Pfizer, and Boehringer Ingelheim – will not have to face around thousands ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to ...

In a 5-0 decision, the Delaware Supreme Court sided with the drugmakers GSK (GSK.L), Pfizer (PFE.N), Sanofi (SASY.PA) and Boehringer Ingelheim.

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world's leading ...

For patients with diabetes, access to healthcare can be a daunting challenge. Boehringer Ingelheim Greece, alongside its partners, is addressing this issue with the 'Sailboat for Health' initiative.